News:AMYPAD
Read the latest news about AMYPAD project, a European collaboration to improve the knowledge, diagnosis and treatment of Alzheimer's by using a Positron Emission Tomography (PET).
The European AMYPAD study demonstrates the efficacy of amyloid PET as a diagnostic tool
Thanks to this neuroimaging technique, widely used in the field of research, deposits of the Alzheimer’s disease associated amyloid-β protein in the brain can be detected and evaluated.
The AMYPAD project is successfully completed
The consortium has officially ended its formal operation after six years of joint efforts and collaboration.
The AMYPAD study performs amyloid PET tests on 840 European participants
The research center of the Pasqual Maragall Foundation, the BBRC, participates in the project, together with seven other European centers.
Discover BBRC’s participation in the Alzheimer’s Association International Conference (AAIC 2021)
The team of the research center of the Pasqual Maragall Foundation presents 6 oral communications and 15 posters, and participates in about fifteen international collaborations
European researchers improve the sensitivity to detect the early stages of Alzheimer's disease
A team of researchers from the AMYPAD consortium, led at BBRC, showed that the visual assessment used in clinical practice to evaluate amyloid PET images is sensitive to detecting the earliest stages of Alzheimer’s disease, and suggests a method to classify the extent of the pathology in the brain.
BBRC researchers participate in the General Assembly of the AMYPAD project
The meeting took place on October 10 and 11 in Barcelona
BBRC’s team of researchers participates in the Alzheimer's Association International Conference 2019
The group of scientists has presented in Los Angeles a total of 8 oral communications and 14 scientific posters
NEURONET will boost synergy and collaboration across IMI’s projects in neurodegenerative disorders
Dr José Luis Molinuevo will be the representative of AMYPAD at the Scientific Coordination Board of the new European project
BBRC researchers participate in the 14th International Conference on Alzheimer’s & Parkinson’s Diseases
Dr José Luis Molinuevo is participating in several sessions of the congress that is taking place in Lisbon, from the 26th to the 31st of March
